Fredy Suter

Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV Genotype 2 or 3

Mitchell L. Shiffman, Fredy Suter, Bruce R. Bacon et al. · New England Journal of Medicine · 2007 · 490 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: An analysis from the ICE Prospective Cohort Study (ICE-PCS)

Stuart A. Dickerman, Elías Abrutyn, Bruno Baršić et al. · American Heart Journal · 2007 · 375 citations

Veterinary Medicine, Infectious Diseases, Internal Medicine +12

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial

José Valdez Madruga, Daniel Berger, Marilyn McMurchie et al. · The Lancet · 2007 · 332 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Health Care–Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition

Natividad Benito, José M. Miró, Elisa de Lazzari et al. · Annals of Internal Medicine · 2009 · 280 citations · Full text

Medicine, Cardiology, Infectious Diseases +16

Similar Adherence Rates Favor Different Virologic Outcomes for Patients Treated with Nonnucleoside Analogues or Protease Inhibitors

Franco Maggiolo, Laura Ravasio, D Ripamonti et al. · Clinical Infectious Diseases · 2004 · 222 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17